New initiative focuses on patients with the rarest of gene mutations to develop personalized ALS therapies

A new initiative, Silence ALS, will develop experimental personalized therapies to treat patients with rare genetic forms of ALS (also known as Lou Gehrig's disease).

Related Keywords

,Stanley Crooke ,Lou Gehrig ,Neil Shneider ,Emily Henderson ,Lorem Foundation ,Columbia University ,Columbia University Vagelos College ,Genetic ,Antisense ,Drugs ,Gene ,Lou Gehrig 39s Disease ,Utation ,Oligonucleotides ,Public Health ,Research ,Na ,